Tempus AI (TEM) EBT Margin (2023 - 2026)
Tempus AI's (TEM) quarterly EBT Margin came in at 2.3% in Q2 2026, up 1519.0% year-over-year from 0.14% in Q2 2025, and up 106.53% quarter-over-quarter from 35.3% in Q1 2026.
Analysis
Tempus AI (TEM) EBT Margin (2023 - 2026) Analysis & Trends
Tempus AI (TEM) has reported EBT Margin for 4 consecutive years, with 2.3% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin rose 1519.0% year-over-year to 2.3% in Q2 2026; TTM through Jun 2026 was 17.62%, a 731.0% increase from a year earlier, with the FY2025 full-year figure at 22.89%, up 7825.0% from the prior year.
- EBT Margin was 2.3% for Q2 2026 at Tempus AI, up from 35.3% in the prior quarter.
- Over five years, EBT Margin peaked at 2.3% in Q2 2026 and troughed at 332.66% in Q2 2024.
- A 4-year average of 51.39% and a median of 35.3% in 2026 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 29063 bps in 2024 and surged 31978 bps in 2025, its largest moves.
- Over 4 years, EBT Margin stood at 34.03% in 2023, then surged by 85 bps to 5.16% in 2024, then plunged by 201 bps to 15.52% in 2025, then soared by 115 bps to 2.3% in 2026.
- The last three EBT Margin figures came in at 2.3% (Q2 2026), 35.3% (Q1 2026), and 15.52% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | -8.93% |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 10.36% |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | 13.54% |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | -35.81% |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | 2.30% |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | -0.23% |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 24.29% |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 6.87% |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | -0.17% |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | -22.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30% |
| Mar 31, 2026 | -35.30% |
| Dec 31, 2025 | -15.52% |
| Sep 30, 2025 | -24.30% |
| Jun 30, 2025 | -12.88% |
| Mar 31, 2025 | -43.93% |
| Dec 31, 2024 | -5.16% |
| Sep 30, 2024 | -40.96% |
| Jun 30, 2024 | -332.66% |
| Mar 31, 2024 | -44.39% |
| Dec 31, 2023 | -34.03% |
| Sep 30, 2023 | -39.22% |
| Jun 30, 2023 | -42.03% |